Brief: Canbridge Pharmaceuticals Inc To Issue Aggregate Of 84 Million Subscription Shares
16/02/2026 01:29
Feb 16 (Reuters) - Canbridge Pharmaceuticals Inc 1228.HK: TO ISSUE AGGREGATE OF 84 MILLION SUBSCRIPTION SHARES AT HK$2.38 PER SHARE Further company coverage: 1228.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CANbridge Pharmaceuticals
See all newsChina's CANbridge Pharmaceuticals H1 revenue rises on Hunterase and Livmarli strength
Brief: CANbridge Pharmaceuticals Posts HY Loss of RMB37.1 MLN
Brief: Canbridge Pharmaceuticals Says Livmarli Obtains NHIA Reimbursement Approval In Taiwan For ALGS And PFIC
Brief: Canbridge Pharmaceuticals Initiates Registration And Launch Preparations For Gaurunning In North African Market
CANbridge Pharmaceuticals jumps as WuXi Biologics buys shares